Pages that link to "Q27301268"
Jump to navigation
Jump to search
The following pages link to A Drosophila model of ALS: human ALS-associated mutation in VAP33A suggests a dominant negative mechanism (Q27301268):
Displaying 50 items.
- The ALS8 protein VAPB interacts with the ER-Golgi recycling protein YIF1A and regulates membrane delivery into dendrites (Q24294526) (← links)
- VAPB interacts with the mitochondrial protein PTPIP51 to regulate calcium homeostasis (Q24298739) (← links)
- Characterization of the Properties of a Novel Mutation in VAPB in Familial Amyotrophic Lateral Sclerosis (Q24302479) (← links)
- Identification and functional analysis of a SLC33A1: c.339T>G (p.Ser113Arg) variant in the original SPG42 family (Q24306772) (← links)
- Sperm and oocyte communication mechanisms controlling C. elegans fertility (Q24626882) (← links)
- The Presynaptic Microtubule Cytoskeleton in Physiological and Pathological Conditions: Lessons from Drosophila Fragile X Syndrome and Hereditary Spastic Paraplegias (Q26738451) (← links)
- Inter-organelle ER-endolysosomal contact sites in metabolism and disease across evolution (Q26739484) (← links)
- Golgi Fragmentation in ALS Motor Neurons. New Mechanisms Targeting Microtubules, Tethers, and Transport Vesicles (Q26773168) (← links)
- The Crossroads of Synaptic Growth Signaling, Membrane Traffic and Neurological Disease: Insights from Drosophila (Q26780007) (← links)
- Autophagy and Neurodegeneration: Insights from a Cultured Cell Model of ALS (Q26796599) (← links)
- Disruption of axonal transport perturbs bone morphogenetic protein (BMP)--signaling and contributes to synaptic abnormalities in two neurodegenerative diseases (Q27315692) (← links)
- Growth differentiation factor 6 as a putative risk factor in neuromuscular degeneration (Q27321426) (← links)
- Amyotrophic lateral sclerosis-linked mutant VAPB inclusions do not interfere with protein degradation pathways or intracellular transport in a cultured cell model (Q27324123) (← links)
- Drosophila as an In Vivo Model for Human Neurodegenerative Disease (Q28088777) (← links)
- Structural, stability, dynamic and binding properties of the ALS-causing T46I mutant of the hVAPB MSP domain as revealed by NMR and MD simulations (Q28477745) (← links)
- A Drosophila model of GSS syndrome suggests defects in active zones are responsible for pathogenesis of GSS syndrome (Q30509496) (← links)
- The amyotrophic lateral sclerosis 8 protein, VAP, is required for ER protein quality control (Q30574388) (← links)
- Interactions between Tau and α-synuclein augment neurotoxicity in a Drosophila model of Parkinson's disease (Q30577687) (← links)
- Protein Quality Control and the Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Continuum (Q33653996) (← links)
- Modelling amyotrophic lateral sclerosis: progress and possibilities (Q33746289) (← links)
- Transgenic Drosophila models of Alzheimer's disease and tauopathies (Q33770749) (← links)
- MSP hormonal control of the oocyte MAP kinase cascade and reactive oxygen species signaling. (Q33828434) (← links)
- Neurotrophic growth factors for the treatment of amyotrophic lateral sclerosis: where do we stand? (Q33985590) (← links)
- Drosophila melanogaster in the study of human neurodegeneration (Q34022667) (← links)
- Neurodegenerative models in Drosophila: polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis (Q34079770) (← links)
- Zebrafish atlastin controls motility and spinal motor axon architecture via inhibition of the BMP pathway (Q34142763) (← links)
- Clinical and genetic diversity of SMN1-negative proximal spinal muscular atrophies (Q34399213) (← links)
- A genetic screen identifies Tor as an interactor of VAPB in a Drosophila model of amyotrophic lateral sclerosis. (Q34515862) (← links)
- Flightless flies: Drosophila models of neuromuscular disease (Q34708090) (← links)
- β-N-methylamino-L-alanine induces neurological deficits and shortened life span in Drosophila (Q35155641) (← links)
- Downregulation of VAPB expression in motor neurons derived from induced pluripotent stem cells of ALS8 patients (Q35175041) (← links)
- Network analyses reveal novel aspects of ALS pathogenesis (Q35234991) (← links)
- A fruitful endeavor: modeling ALS in the fruit fly (Q35268719) (← links)
- Secreted VAPB/ALS8 major sperm protein domains modulate mitochondrial localization and morphology via growth cone guidance receptors. (Q35819129) (← links)
- Amyotrophic lateral sclerosis-associated mutant VAPBP56S perturbs calcium homeostasis to disrupt axonal transport of mitochondria (Q35860341) (← links)
- A Presynaptic Regulatory System Acts Transsynaptically via Mon1 to Regulate Glutamate Receptor Levels in Drosophila. (Q36132319) (← links)
- Vapb/Amyotrophic lateral sclerosis 8 knock-in mice display slowly progressive motor behavior defects accompanying ER stress and autophagic response (Q36188594) (← links)
- Widespread aggregation of mutant VAPB associated with ALS does not cause motor neuron degeneration or modulate mutant SOD1 aggregation and toxicity in mice (Q36513305) (← links)
- Insights into ALS pathomechanisms: from flies to humans (Q36782137) (← links)
- Probing mechanisms that underlie human neurodegenerative diseases in Drosophila (Q36873362) (← links)
- Increased levels of phosphoinositides cause neurodegeneration in a Drosophila model of amyotrophic lateral sclerosis (Q36908231) (← links)
- Drosophila melanogaster as a model organism of brain diseases (Q37139826) (← links)
- Recent advances in using Drosophila to model neurodegenerative diseases (Q37448324) (← links)
- Gain-of-function mutations in the ALS8 causative gene VAPB have detrimental effects on neurons and muscles (Q37480373) (← links)
- The BMP signaling pathway at the Drosophila neuromuscular junction and its links to neurodegenerative diseases. (Q37787429) (← links)
- Stress signaling from the endoplasmic reticulum: A central player in the pathogenesis of amyotrophic lateral sclerosis. (Q37915428) (← links)
- Dissection and imaging of active zones in the Drosophila neuromuscular junction. (Q38353292) (← links)
- Structural requirements for VAP-B oligomerization and their implication in amyotrophic lateral sclerosis-associated VAP-B(P56S) neurotoxicity. (Q40188215) (← links)
- Neuronal overexpression of human VAPB slows motor impairment and neuromuscular denervation in a mouse model of ALS. (Q40345993) (← links)
- Amyotrophic lateral sclerosis (ALS)-associated VAPB-P56S inclusions represent an ER quality control compartment (Q41874848) (← links)